GLP-1 receptor agonist medications (including semaglutide, dulaglutide, liraglutide, exenatide, and lixisenatide) are typically considered for type 2 diabetes when: Triple therapy with other diabetes medications is not effective, not tolerated, or contraindicated The person has a BMI 35 kg/m (adjusted by 2.5 kg/m for people from South Asian, Chinese, other Asian, Black African, or African-Caribbean backgrounds) and specific weight-related psychological or medical problems A lower BMI threshold may be appropriate if weight loss would benefit other obesity-related comorbidities Insulin would not be appropriate or acceptable to the person Treatment is usually continued only if there is a beneficial metabolic response (reduction in HbA1c and weight) after 6 months
Obes Surg (2008) 18(9):11837
The program also includes supplemental medications when clinically appropriate, such as metformin, phentermine, or nausea medication, along with injection supplies and medication shipping for added convenience
Between services, savor a gourmet spa lunch prepared by our in-house chef, paired with a glass of wine for a touch of indulgence
